Show simple item record

dc.contributor.authorMichelson, Alan D.
dc.date2022-08-11T08:10:11.000
dc.date.accessioned2022-08-23T16:58:36Z
dc.date.available2022-08-23T16:58:36Z
dc.date.issued2006-05-01
dc.date.submitted2012-04-25
dc.identifier.citationPathophysiol Haemost Thromb. 2006;35(1-2):5-9. doi: 10.1159/000093570
dc.identifier.issn1424-8832 (Linking)
dc.identifier.doi10.1159/000093570
dc.identifier.pmid16855339
dc.identifier.urihttp://hdl.handle.net/20.500.14038/43403
dc.description.abstractDescribes the concept, mechanisms, adverse clinical events, and treatment of aspirin resistance as related to coronary arterial thrombosis.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16855339&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1159/000093570
dc.subjectAspirin
dc.subjectBlood Platelets
dc.subjectCardiovascular Diseases
dc.subjectDrug Resistance
dc.subjectHumans
dc.subjectHematology
dc.subjectOncology
dc.subjectPediatrics
dc.titleAspirin resistance
dc.typeJournal Article
dc.source.journaltitlePathophysiology of haemostasis and thrombosis
dc.source.volume35
dc.source.issue1-2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/peds_hematology/81
dc.identifier.contextkey2796571
html.description.abstract<p>Describes the concept, mechanisms, adverse clinical events, and treatment of aspirin resistance as related to coronary arterial thrombosis.</p>
dc.identifier.submissionpathpeds_hematology/81
dc.contributor.departmentDepartment of Pediatrics
dc.source.pages5-9


This item appears in the following Collection(s)

Show simple item record